Sign Up Today and Learn More About BillionToOne Stock
Invest in or calculate the value of your shares in BillionToOne or other pre-IPO companies through EquityZen's platform.
BillionToOne Stock (BIIT)
BillionToOne is a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all.
About BillionToOne Stock
Founded
2016
Headquarters
Menlo Park, CA, US
Industries
Travel and Tourism, Space, Manufacturing
BillionToOne Press Mentions
Stay in the know about the latest news on BillionToOne
Non-Cancer Liquid Biopsy Testing Market to Quadruple Reaching US$ 19.3 Billion by 2035: Evaluation of Key Business Opportunities, Challenges and Company Strategies
globenewswire • Nov 04, 2025
Molecular Diagnostics for Cancer Markets Forecasts 2025-2030 by Cancer Type, Product and Place with Executive and Consultant Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com
businesswire • Nov 04, 2025
US IPO Week Ahead: Beta Technologies leads flurry of debuts as shutdown rolls on
renaissancecapital • Nov 01, 2025
BillionToOne launches IPO roadshow
thefly • Oct 31, 2025
BillionToOne announces launch of initial public offering roadshow
marketscreener • Oct 30, 2025
BillionToOne Management
Leadership team at BillionToOne
Co-Founder
Oguzhan Atay
CTO
David Tsao
Join now and verify your accreditation status to gain access to:
- BillionToOne Current Valuation
- BillionToOne Stock Price
- BillionToOne Management
- Available deals in BillionToOne and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- BillionToOne Cap Table and Funding History by Share Class and Liquidity Preferences
- BillionToOne Revenue and Financials
- BillionToOne Highlights
- BillionToOne Business Model
- BillionToOne Risk Factors
- BillionToOne Research Report from SACRA Research
Trading BillionToOne Stock
How to invest in BillionToOne stock?
Accredited investors can buy pre-IPO stock in companies like BillionToOne through EquityZen funds. These investments are made available by existing BillionToOne shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BillionToOne stock?
Shareholders can sell their BillionToOne stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
